228 related articles for article (PubMed ID: 18561506)
1. New anticoagulant strategies in ST elevation myocardial infarction: trials and clinical implications.
McCann CJ; Menown IB
Vasc Health Risk Manag; 2008; 4(2):305-13. PubMed ID: 18561506
[TBL] [Abstract][Full Text] [Related]
2. Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where?
Lincoff AM
Am Heart J; 2003 Oct; 146(4 Suppl):S23-30. PubMed ID: 14564303
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials of conjunctive anticoagulant strategies in thrombolysis.
Kleiman NS
Coron Artery Dis; 1996 Jul; 7(7):508-15. PubMed ID: 8913678
[No Abstract] [Full Text] [Related]
4. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
Lepor NE
Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
[TBL] [Abstract][Full Text] [Related]
5. New anticoagulant options for ST-elevation myocardial infarction and unstable angina pectoris/non-ST-elevation myocardial infarction.
Bates ER
Curr Cardiol Rep; 2007 Jul; 9(4):289-97. PubMed ID: 17601395
[TBL] [Abstract][Full Text] [Related]
6. The quality of antiplatelet and anticoagulant medication administration among ST-segment elevation myocardial infarction patients transferred for primary percutaneous coronary intervention.
Wang TY; Magid DJ; Ting HH; Li S; Alexander KP; Roe MT; Peterson ED
Am Heart J; 2014 Jun; 167(6):833-9. PubMed ID: 24890532
[TBL] [Abstract][Full Text] [Related]
7. Current anticoagulation options in percutaneous intervention: designing patient-specific strategies.
French MH; Faxon DP
Rev Cardiovasc Med; 2002; 3(4):176-82. PubMed ID: 12556751
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors.
Bangalore S; Toklu B; Kotwal A; Volodarskiy A; Sharma S; Kirtane AJ; Feit F
BMJ; 2014 Nov; 349():g6419. PubMed ID: 25389143
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in acute coronary syndromes.
Iqbal MB; Westwood MA; Swanton RH
Clin Med (Lond); 2008 Feb; 8(1):42-8. PubMed ID: 18335668
[TBL] [Abstract][Full Text] [Related]
10. Improving adjunctive pharmacotherapy for primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: beyond the HORIZONS-AMI trial.
Kereiakes DJ
Rev Cardiovasc Med; 2009; 10(2):72-82. PubMed ID: 19593319
[TBL] [Abstract][Full Text] [Related]
11. Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry--GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry--Get With the Guidelines).
Kadakia MB; Desai NR; Alexander KP; Chen AY; Foody JM; Cannon CP; Wiviott SD; Scirica BM;
JACC Cardiovasc Interv; 2010 Nov; 3(11):1166-77. PubMed ID: 21087753
[TBL] [Abstract][Full Text] [Related]
12. 2007 Guideline update for unstable angina/non-ST-segment elevation myocardial infarction: focus on antiplatelet and anticoagulant therapies.
Coons JC; Battistone S
Ann Pharmacother; 2008 Jul; 42(7):989-1001. PubMed ID: 18577763
[TBL] [Abstract][Full Text] [Related]
13. Bivalirudin for percutaneous coronary intervention and in acute coronary syndromes.
Bates ER
Curr Cardiol Rep; 2001 Sep; 3(5):348-54. PubMed ID: 11504570
[TBL] [Abstract][Full Text] [Related]
14. Direct thrombin inhibitors (part 2 of 2).
Arora UK; Dhir M
J Invasive Cardiol; 2005 Feb; 17(2):85-91. PubMed ID: 15687531
[No Abstract] [Full Text] [Related]
15. Hirudin and hirudin analogues as new anticoagulant agents.
Pineo GF; Hull RD
Curr Opin Hematol; 1995 Sep; 2(5):380-5. PubMed ID: 9372023
[TBL] [Abstract][Full Text] [Related]
16. Fondaparinux in the management of patients with ST-elevation acute myocardial infarction.
Turpie AG
Vasc Health Risk Manag; 2006; 2(4):371-8. PubMed ID: 17323591
[TBL] [Abstract][Full Text] [Related]
17. Bivalirudin: a review of its potential place in the management of acute coronary syndromes.
Carswell CI; Plosker GL
Drugs; 2002; 62(5):841-70. PubMed ID: 11929334
[TBL] [Abstract][Full Text] [Related]
18. Treatment of heparin-induced thrombocytopenia in cardiovascular patients.
Matthai WH
Expert Opin Pharmacother; 2006 Feb; 7(3):267-76. PubMed ID: 16448321
[TBL] [Abstract][Full Text] [Related]
19. Advances in antithrombotic therapy: novel agents.
Turpie AG; Weitz JI; Hirsh J
Thromb Haemost; 1995 Jul; 74(1):565-71. PubMed ID: 8578525
[TBL] [Abstract][Full Text] [Related]
20. Heparin Versus Bivalirudin Monotherapy in the Setting of Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction.
Faulkenberg KD; Beavers JC; Finks SW
Ann Pharmacother; 2016 Feb; 50(2):141-51. PubMed ID: 26681442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
